1.
Fructose and metabolic diseases: New findings, new questions
by Tappy, Luc, M.D
Nutrition (Burbank, Los Angeles County, Calif.), 2010, Vol.26 (11), p.1044-1049
2.
Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
by Iglay, Kristy
Current medical research and opinion, 2016, Vol.32 (7), p.1243-1252
3.
Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA
by Bauer, Ursula E, PhD
The Lancet (British edition), 2014, Vol.384 (9937), p.45-52
4.
Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema
by Augustin, Matthias
Dermatology (Basel), 2015, Vol.231 (1), p.35-40
5.
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study
by Haag, M D M
Journal of neurology, neurosurgery and psychiatry, 2009, Vol.80 (1), p.13-17
6.
Multimorbidity and the Risk of Hospitalization and Death in Atrial Fibrillation: A Population-Based Study
by Chamberlain, Alanna M
The American heart journal, 2016, Vol.185, p.74-84
7.
Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency
by Stewart, Paul M
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (12), p.4843-4850
8.
Toxicity risk from glucocorticoids in sarcoidosis patients
by Khan, Nauman A
Respiratory medicine, 2017, Vol.132, p.9-14
9.
Obesity and hyperlipidemia are risk factors for early diabetic neuropathy
by Smith, A. Gordon
Journal of diabetes and its complications, 2013, Vol.27 (5), p.436-442
10.
Age-Specific Gender Differences in In-Hospital Mortality by Type of Acute Myocardial Infarction
by Zhang, Zefeng, MD, PhD
The American journal of cardiology, 2012, Vol.109 (8), p.1097-1103
11.
Diabetic dyslipidaemia: from basic research to clinical practice
by TASKINEN, M.-R
Diabetologia, 2003, Vol.46 (6), p.733-749
12.
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial
by Rajamani, Kushwin, Dr
The Lancet (British edition), 2009, Vol.373 (9677), p.1780-1788
13.
Attenuating the mortality risk of high serum uric acid: the role of physical activity underused
by Chen, Jiunn-Horng
Annals of the rheumatic diseases, 2015, Vol.74 (11), p.2034-2042
14.
Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study
by Pappas, Dimitrios A
Clinical rheumatology, 2018, Vol.37 (9), p.2331-2340
15.
Fasting Plasma Glucose and Serum Lipids in Patients With Primary Aldosteronism: A Controlled Cross-Sectional Study
by Matrozova, Joanna
Hypertension (Dallas, Tex. 1979), 2009, Vol.53 (4), p.605-610
16.
Evaluation of daily ginger consumption for the prevention of chronic diseases in adults: A cross-sectional study
by Wang, Yu
Nutrition (Burbank, Los Angeles County, Calif.), 2017, Vol.36, p.79-84
17.
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus : a cohort study
by CARR, A
The Lancet (British edition), 1999, Vol.353 (9170), p.2093-2099
18.
Cardiovascular Risk Factors as Causes for Hearing Impairment
by Oron, Yahav
Audiology & neurotology, 2014, Vol.19 (4), p.256-260
19.
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease
by Steinberg, Benjamin A., MD
The American heart journal, 2008, Vol.156 (4), p.719-727
20.
Prevalence and risk factors associated with hyperuricemia among working population at high altitudes: a cross-sectional study in Western China
by Shen, Yang
Clinical rheumatology, 2019, Vol.38 (5), p.1375-1384
